What is the ticker symbol for Sensei Biotherapeutics?

Sensei Biotherapeutics trades under the ticker SNSE on NASDAQ.

What sector does Sensei Biotherapeutics operate in?

Sensei Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SNSE in a portfolio?

PortView shows SNSE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Sensei Biotherapeutics (SNSE) Stock Analysis

NASDAQHealthcareBiotechnology

$13.85-22.28%

1-year price historyRange $6.80 – $36.16

52-week range$13.85

$6.33$36.76

What Sensei Biotherapeutics does

Sensei Biotherapeutics, Inc. (SNSE) is a biopharmaceutical firm dedicated to discovering and advancing immunotherapies, primarily for cancer treatment. The company's innovative approaches include its proprietary ImmunoPhage platform. This immunotherapy leverages bacteriophages to orchestrate a precise and robust innate and adaptive immune response. They also employ the Tumor Microenvironment Activated Biologics (TMAB) platform. This system is engineered to unleash T-cells' anti-tumor capabilities, utilizing human monoclonal antibodies specifically designed to operate within the tumor's immediate environment and target key immune checkpoints or other crucial signaling pathways. Sensei Biotherapeutics' pipeline features SNS-101, a monoclonal antibody developed for cancer therapy, and SNS-401-NG, an ImmunoPhage vaccine engineered to target a range of tumor antigens. Furthermore, they collaborate with The University of Washington on the research and development of a vaccine for Merkel cell carcinoma. Established in 1999, originally as Panacea Pharmaceuticals, Inc., Sensei Biotherapeutics maintains its headquarters in Rockville, Maryland.

Key metrics

Market cap

$18.59M

P/E (TTM)

-0.10

EPS (TTM)

$-142.72

Beta

-0.23

Dividend yield

0.00%

Revenue / share

$-0.86

50-day avg

$21.49

200-day avg

$16.71

52-week high

$36.76

52-week low

$6.33

CEO

Christopher W. Gerry

ETFs linked to SNSE

Broad-market and Healthcare sector ETFs an investor holding Sensei Biotherapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SNSE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SNSE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Sensei Biotherapeutics?: Sensei Biotherapeutics trades under the ticker SNSE on NASDAQ.
Which exchange is SNSE listed on?: SNSE is listed on NASDAQ.
What sector does Sensei Biotherapeutics operate in?: Sensei Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SNSE in a portfolio?: PortView shows SNSE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.